PlainRecalls
FDA Drug Moderate Class II Terminated

Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05

Reported: March 11, 2015 Initiated: February 23, 2015 #D-0398-2015

Product Description

Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05

Reason for Recall

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Details

Units Affected
140,720 vials
Distribution
Nationwide and Puerto Rico
Location
Schaumburg, IL

Frequently Asked Questions

What product was recalled?
Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05. Recalled by Sagent Pharmaceuticals Inc. Units affected: 140,720 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 11, 2015. Severity: Moderate. Recall number: D-0398-2015.